Omas, Ailjie B.

HRN: 26-67-97  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/10/2025
CEFUROXIME 750MG (VIAL)
02/10/2025
02/17/2025
IV
343
Q8h
UTI
Waiting Final Action 
02/11/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/11/2025
02/17/2025
IVT
300mg
Q8
Amoebiasis
Waiting Final Action 
02/12/2025
CEFTRIAXONE 1G (VIAL)
02/12/2025
02/17/2025
IV
1g
Q24
Typhoid Fever
Waiting Final Action 
02/16/2025
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
02/16/2025
02/22/2025
ORAL
2.6ml
OD
Typhoid Fever
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: